Table 3.
Comparison of the improvement level and the efficacy index at two and four weeks between the two groups.
Two weeks | Four weeks | |||||
---|---|---|---|---|---|---|
Nanocurcumin n(%) | Placebo n (%) | P value | Nanocurcumin n (%) | Placebo n (%) | P value | |
Healed | 0 (0%) | 0 (0%) | <0.001 | 0 (0%) | 0 (0%) | 0.001 |
Marked improvement | 2 (14.3%) | 0 (0%) | 7 (50%) | 1 (5.9%) | ||
Moderate improvement | 11 (78.6%) | 3 (17.6%) | 7 (50%) | 9 (52..9%) | ||
No improvement | 1 (7.1%) | 14 (82.4%) | 0 (0%) | 7 (41.2%) | ||
| ||||||
EI mean (SD) | 54.60 (17.05) | 24.63 (11.71) | <0.001 | 63.04 (13.94) | 36.46(17.53) | <0.001 |